- Home
- PBYI vs BRAG Comparison
PBYI vs BRAG Comparison
Compare PBYI & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BRAG
- Stock Information
- Founded
- PBYI 2010
- BRAG 2018
- Country
- PBYI United States
- BRAG Canada
- Employees
- PBYI N/A
- BRAG N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- PBYI Health Care
- BRAG Technology
- Exchange
- PBYI Nasdaq
- BRAG Nasdaq
- Market Cap
- PBYI 145.3M
- BRAG 138.8M
- IPO Year
- PBYI N/A
- BRAG N/A
- Fundamental
- Price
- PBYI $2.91
- BRAG $5.44
- Analyst Decision
- PBYI Strong Buy
- BRAG Strong Buy
- Analyst Count
- PBYI 1
- BRAG 4
- Target Price
- PBYI $7.00
- BRAG $7.75
- AVG Volume (30 Days)
- PBYI 288.9K
- BRAG 86.6K
- Earning Date
- PBYI 02-27-2025
- BRAG 03-25-2025
- Dividend Yield
- PBYI N/A
- BRAG N/A
- EPS Growth
- PBYI 492.79
- BRAG N/A
- EPS
- PBYI 0.47
- BRAG N/A
- Revenue
- PBYI $243,569,000.00
- BRAG $109,522,641.00
- Revenue This Year
- PBYI N/A
- BRAG $11.40
- Revenue Next Year
- PBYI N/A
- BRAG $10.75
- P/E Ratio
- PBYI $6.24
- BRAG N/A
- Revenue Growth
- PBYI 6.30
- BRAG 4.64
- 52 Week Low
- PBYI $2.23
- BRAG $2.86
- 52 Week High
- PBYI $7.15
- BRAG $7.00
- Technical
- Relative Strength Index (RSI)
- PBYI 48.76
- BRAG 59.49
- Support Level
- PBYI $2.69
- BRAG $5.11
- Resistance Level
- PBYI $2.98
- BRAG $6.12
- Average True Range (ATR)
- PBYI 0.12
- BRAG 0.33
- MACD
- PBYI 0.01
- BRAG -0.04
- Stochastic Oscillator
- PBYI 58.11
- BRAG 52.05
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.